INS and obesity disorder: Intermediates of PI play key roles in integrating the insulin-stimulated receptor with the cell membrane translocation of the glucose transporter 4 [53] and are involved in the development of obesity [54], particularly phosphatidylinositol-3,4,5-trisphosphate, which activates protein kinase B [55].